Syros Pharmaceuticals

• NCT06085638

  Collaborator, Phase 1/2, Withdrawn, 0 people, 17 Oct 2023

• NCT04905407

  Phase 2, Terminated, 66 people, 27 May 2021

• NCT04247126

  Phase 1, Completed, 105 people, 29 Jan 2020

• NCT03134638

  Phase 1, Terminated, 107 people, 1 May 2017

• Human brain organoids record the passage of time over multiple years

  Consulting or advice, Board or leadership role, 19 Aug 2026

• Modulation of the clonal burden in patients with lower-risk myelodysplastic neoplasms treated with imetelstat

  Consulting or advice, Fees or honoraria, Grants or research support, Board or leadership role, 12 Jan 2026

• Tissue and cellular spatiotemporal dynamics in colon aging

  Consulting or advice, Board or leadership role, 22 Oct 2025

• A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories

  Consulting or advice, Board or leadership role, 8 May 2023

• Heterochronic parabiosis reprograms the mouse brain transcriptome by shifting aging signatures in multiple cell types

  Consulting or advice, 9 Mar 2023

Sources: pubmed.ncbi.nlm.nih.gov